Dmitry Avtonomov

[Enveda @enveda]

Raising $150M wasn’t the only headline.

Discovery is nothing without delivery
ENV-294, our lead drug for #atopicdermatitis, has entered Phase 1b. A completely new way of tackling this disease, and potentially others across #inflammation, is playing out in patients.

Experience that shapes the industry
Mikael Dolsten joins Enveda. Former CSO of Pfizer, with 36 approvals and 150+ candidates. He knows what it takes to turn science into #medicines that matter.

This is just the beginning.

Read more in our announcement: https://t.co/1wE3tA4mRy

[Enveda @enveda]

Today’s spotlight in #TimesSquare marks more than our Series D raise and #unicorn milestone. It is a reflection of the bold vision and relentless work of our team, who are advancing a new standard in drug discovery and building a generational company.

Moments like this remind us why we started and what we are capable of achieving together. Seeing Enveda featured on the @Nasdaq Tower is a proud milestone... and it's just the beginning. Thank you for featuring Enveda!

#AI #DrugDiscovery #Nature

[Enveda @enveda]

In case you missed it! @viswacolluru joined @KristenScholer at the @NYSE this morning for a live broadcast from the trading floor about Enveda's $150 Series D and what it takes to become a unicorn.

Thank you to Eric Dimise, PhD, Johanna Grossman, PhD Grossman and colleagues at the NYSE for celebrating our Series D!

[Enveda @enveda]

How we built a unicorn from seed in 5 years…

There are no secrets, but purpose, pace, and an incredible team certainly help.

“We’re combining ancient ancestral wisdom with the power of nature’s chemistry with modern AI and drug discovery,” Colluru said. “We’re standing on the shoulders of maybe the giant, which is Mother Nature.”

Read more by @damiangarde in @business about how we raised our Series D, advanced our lead candidate in atopic dermatitis to Phase 1b, and brought on a pharma legend Mikael Dolsten as we prepare to enter more programs in the clinic this year... and stay tuned for more.

#Unicorn #Startups #AI #DrugDiscovery #Nature

[Enveda @enveda]

More than a clinical milestone – this marks real momentum for our lead asset.

Our first-in-class oral therapeutic, ENV-294, cleared a major Phase I milestone with favorable safety results and it's showing potential to transform care for #atopicdermatitis patients. Read more: https://t.co/qhM28L6d89

Why does this matter?

Because 200M+ people worldwide live with atopic dermatitis—yet, there’s a massive unmet need for safe, effective, and convenient options.

We are excited to be launching our Phase 1b trial later this year, designed to further evaluate safety, tolerability, pharmacokinetics, target engagement, and early signs of efficacy in atopic dermatitis patients… stay tuned.

#DrugDiscovery #AI #ClinicalTrials #Biotech #Inflammation

[Dmitry Avtonomov @dmtavt]

@gwaisman But that is significantly higher than would be considered ok

[Bernie Sanders @BernieSanders]

In this dangerous moment – COVID, oligarchy, economic desperation, climate change, a dysfunctional health care system, systemic racism, etc. – we must continue fighting for a political revolution and transformative change. Nothing less than the future of the world is at stake.

[venus 🧜‍♀️ @VENUS__6942]

@SpaceX @NatReconOfc It's real, and it's spectacular🚀😎 a scension from the future:👽🎥

[Gary Dolinko @GDolinko]

@therecount @Acosta rudy a fool, i mean you tell me

[Dmitry Avtonomov @dmtavt]

@ProteomicsNews On the other hand it's a shame that a company the size of Thermo doesn't sign its software (which is why you see the warning)

[Mashable @mashable]

AI just keeps getting cooler and cooler

[SpaceX @SpaceX]

100 successful flights

[Universal Curiosity @UniverCurious]

Apollo 11 blast off, July 16,1969.

[SpaceX @SpaceX]

Liftoff!

[Mashable @mashable]

Robots can basically do everything now https://t.co/Hkp2WaFVj9

[Mashable @mashable]

This driverless 1981 DeLorean can "drift like a pro"

[Stephan Hacker (inactive account) @StephanHacker2]

I think for once I have a solid theory, why our proteomics MS has stopped measuring. Poor fly. Photo by Alexandra Geißler @SieberLab. Has anyone ever seen this or something as weird on an MS before? @Keribackus @_chrisgparker_ @Abbasov_Cornell @DanNomura @JohnRYatesIII @nesvilab

[Mashable @mashable]

The designer is a GENIUS https://t.co/IwbPCffq32

[Mashable @mashable]

This... might be the best thing to come out of TikTok?

[Dmitry Avtonomov @dmtavt]

@trishnphilly @ravenscimaven Would that be ok had they offered some compensation?